Trabectedin as a Single-Agent Treatment of Advanced Breast Cancer After Anthracycline and Taxane Treatment: A Multicenter, Randomized, Phase II Study Comparing 2 Administration Regimens

2014 ◽  
Vol 14 (6) ◽  
pp. 396-404 ◽  
Author(s):  
Lori J. Goldstein ◽  
Jayne Gurtler ◽  
Salvatore A. Del Prete ◽  
Sergei Tjulandin ◽  
Vladimir F. Semiglazov ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Single Agent ◽  
Advanced Breast ◽  
Randomized Phase Ii ◽  
Agent Treatment

Randomized phase II study of FEC day 1 + 8 and FEC day 1 in patients with advanced breast cancer

2000 ◽  
Vol 60 (1) ◽  
pp. 57-62 ◽  
Author(s):  
D.W. van Toorn ◽  
J.W.R Nortier ◽  
M. Rubach ◽  
C.A.M. de Swart ◽  
J.C. Huldij ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Randomized Phase Ii

scholarly journals A randomized phase II study comparing capecitabine alone with capecitabine and oral cyclophosphamide in patients with advanced breast cancer-cyclox II

2013 ◽  
Vol 24 (7) ◽  
pp. 1828-1834 ◽  
Author(s):  
V.J. Harvey ◽  
K.J. Sharples ◽  
R.J. Isaacs ◽  
M.B. Jameson ◽  
G.M. Jeffery ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Breast ◽  
Oral Cyclophosphamide ◽  
Randomized Phase Ii
Sign in / Sign up

Export Citation Format

Share Document